Hydrocortisone 2-mg/mL in Oral Mix Suspension
Download in electronic PDF format for $75
Abstract: A formulation for preparing Hydrocortisone 2-mg/mL in Oral Mix Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
formulation, hydrocortisone, corticosteroid, oral suspension, adrenal insufficiency, blood cell disorders
Related Categories:
FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, HEMOSTASIS, BLEEDING, ANTICOAGULATION
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 325
|
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
|
Jan/Feb 2018
Pg. 66-75
|
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 315
|
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 415
|
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Sep/Oct 2021
Pg. 431-439
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 44
|
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study
Santoveña A, Llabrés M, Fariña JB
|
Sep/Oct 2010
Pg. 430-435
|
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 505
|
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 416
|
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 47
|
Hydrocortisone 2 mg/mL in Inorpha Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 495
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 235
|
Nitazoxanide 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 420
|
Adrenal Fatigue
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 39-44
|
Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF
Friciu Mihaela, Cull Erica, Leclair Grégoire
|
Sep/Oct 2024
Pg. 408-412
|
Prednisone 5 mg/mL ir Oral Mix Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 497
|
Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 321
|
| Return to Top |
